FDA Import Refusal 1FX-4253504-8/20002/1 — CIPLA LTD
The FDA refused shipment 1FX-4253504-8/20002/1 from CIPLA LTD (India) on Sep 19, 2026. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 19, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XDB45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
- Charges
- 75